Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

SHE:002603 Revenue

Shijiazhuang Yiling Pharmaceutical had revenue of 2.44B CNY in the quarter ending March 31, 2026, with 3.46% growth. This brings the company's revenue in the last twelve months to 7.91B, up 24.64% year-over-year. In the year 2025, Shijiazhuang Yiling Pharmaceutical had annual revenue of 7.83B with 20.24% growth.

• Revenue (ttm): 7.91B
• Revenue Growth: +24.64%
• P/S Ratio: 3.45
• Revenue / Employee: 697.55K
• Employees: 11,343
• Market Cap: 27.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.83B	1.32B	20.24%
Dec 31, 2024	6.51B	-3.81B	-36.88%
Dec 31, 2023	10.32B	-2.21B	-17.67%
Jan 1, 2023	12.53B	2.42B	23.88%
Jan 1, 2022	10.12B	1.33B	15.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error